Complex lymphatic anomalies: Molecular landscape and medical management

This article reviews the molecular mechanisms underlying complex lymphatic anomalies, particularly PIK3CA-related overgrowth disorders, and evidence-based medical management strategies. It addresses targeted therapies including mTOR inhibitors like sirolimus, providing clinicians with current approaches to managing these challenging vascular malformations in pediatric patients.